FDA-Drug2021-09-29Class II
Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32
Glenmark Pharmaceuticals Inc., USA
Hazard
Lack of Assurance of Sterility
Sold states
Nationwide.
Affected count
28658 cartons
Manufactured in
750 Corporate Dr, Mahwah, NJ, United States
Products
Fulvestrant Injection 250 mg/5 mL (50 mg/mL) For Intramuscular Use Only Contains 2 single-dose pre-filled syringes Rx only NDC 68462-317-32
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0820-2021Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief